rule

Classification, calendars and rule changes take center stage at Para Snow Sports Committee meeting in Vilamoura

May 16, 2025 - The FIS Para Snow Sports Committee convened in Vilamoura (POR) on 8 May 2025 to discuss key…

10 hours ago
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 16, 2025 16:01 ET  | Source: aTyr Pharma, Inc. SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma,…

13 hours ago
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 15,…

13 hours ago
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with…

1 day ago
Xilio Therapeutics Announces Inducement Grant UnderNasdaq Listing Rule 5635(c)(4)Xilio Therapeutics Announces Inducement Grant UnderNasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Inducement Grant UnderNasdaq Listing Rule 5635(c)(4)

May 02, 2025 16:30 ET  | Source: Xilio Therapeutics, Inc. WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics,…

2 weeks ago
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 02, 2025 16:42 ET  | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE)…

2 weeks ago
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 11, 2025 16:01 ET  | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio…

1 month ago
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 07, 2025 17:00 ET  | Source: Anika Therapeutics Inc. BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics,…

1 month ago
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

April 04, 2025 16:05 ET  | Source: Syndax Pharmaceuticals, Inc. NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals…

1 month ago
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing…

1 month ago